The shareholders of AcouSort AB (publ), reg. no. 556824-1037, (the “Company”) are hereby given notice to attend the Extraordinary General Meeting (the “EGM”) on 22 October 2026 at 09.00 CEST at Medicon Village (Building 406), Scheelevägen 14, Lund. Registration starts at 08.30 CEST. Right to participateShareholders that wish to participate in the EGM shall both be…
AcouSort AB (publ) (”AcouSort” or the ”Company”) today announces that it has entered into an OEM supply and development agreement (the “OEM Supply Agreement”) and a marketing consulting agreement (the “Marketing Consulting Agreement”) with Calyrex Biosystems Inc. (“Calyrex”) and Calyrex’s associated company, Intelmetis Inc. (“Intelmetis”), respectively. In connection with the broader commercial transaction, the Board…
The “Company” or “AcouSort” refers to AcouSort AB (publ) with corporate registration number 556824–1037 April–June 2026 for the Group• Net sales amounted to TSEK 2,116 (1,551)• Result before tax amounted to TSEK -3,532 (-2,809)• Result per share was SEK -0.17 (-0.14)• Equity ratio amounted to 46% (81%) on June 30, 2026 January–June 2026 for the…
AcouSort has for the third time been invited by the EU Business Hub to participate in marketing and partnering events in East Asia – this time in Osaka, Japan, July 1-4 2026. “For AcouSort, participation in the EU Business Hub provides a great opportunity to meet and connect with Japanese companies active within our target…
AcouSort AB today announced it has received an order from a global leader within veterinary diagnostics based in the US. The company has acquired an AcouWash system to be used in its R&D activities concerning separation of cells from blood samples as well as for separation of cells and microorganisms. “We are very happy to…
AcouSort AB today announced that the company will present a poster showing the benefits of using its technology to improve sample quality before flow cytometry analysis at the annual CYTO conference at the Palm Beach County Convention Center in West Palm Beach, FL, June 6 – 10, 2026. AcouSort will also exhibit at the conference….
The “Company” or “AcouSort” refers to AcouSort AB (publ) with corporate registration number 556824–1037. First quarter 2026 for the GroupNet sales amounted to TSEK 2,147 (1,595)Result before tax amounted to TSEK –2,369 (-4,022)Result per share was SEK -0.10 (-0.27)Equity ratio amounted to 52% (41%) on March 31, 2026 First quarter 2026 for the Parent companyNet sales…
Today, May 20, 2026, AcouSort AB publishes its annual report for the financial year 2025. The report is available in the attached pdf and on the company’s website. FOR FURTHER INFORMATION ABOUT ACOUSORT, PLEASE CONTACT:Torsten Freltoft, CEOTelephone: +45 2045 0854E-mail: torsten.freltoft@acousort.com ABOUT ACOUSORTAcouSort AB (corporate registration number 556824-1037) is an innovative technology company focusing on…
AcouSort AB today announced the sale of an AcouTrap system to a research group led by Alisa Komsky‑Elbaz, PhD, Assistant Professor at the Hebrew University of Jerusalem. “The AcouTrap system is especially suitable for the group’s work as they often work with minute samples that are difficult to handle using other technologies, and where the…
AcouSort AB today announced its German partner Moeller Medical, a developer and manufacturer of high-precision medical solutions, will exhibit a prototype system for analyzing body fluid at the Analytica trade fair in Munich, March 24-27. The system includes AcouSort’s novel AcouWash technology. “This will give us a great opportunity to show integration of our acoustic…
"*" indicates required fields
AcouSort AB
Medicon Village
223 81 Lund
Sweden